文献速递胰腺与胆道疾病消化内镜

胆囊管残端结石致胆囊切除术后综合征的内镜处理:多中心经验

Endoscopic management of cystic duct remnant stones causing postcholecystectomy syndrome: a multicenter experience.
PubMed 文献 · Gastrointest Endosc · 2026-08-10

多中心回顾性研究纳入21例因胆囊管残端结石导致胆囊切除术后综合征的患者行ERCP治疗,技术和临床成功率分别为95%和91%,术后胰腺炎发生率10%且均为轻度,提示ERCP高效安全,胆道镜联合EHL常需预先准备。

要点

  • ERCP治疗胆囊管残端结石技术成功率95%,临床成功率91%。
  • 43%病例需胆道镜,其中89%使用EHL,尤见于嵌顿或大结石。
  • 术后胰腺炎发生率10%,均为轻度,安全性可接受。

核心结论

  • ERCP对症状性胆囊管残端结石高效且安全,胆道镜联合EHL常需预先准备。

研究设计与样本

  • 回顾性多中心研究,纳入21例因胆囊管残端结石导致胆囊切除术后综合征并接受ERCP的患者,平均年龄50±17岁。

主要发现

  • 技术成功(完全清除结石)率为95%(20/21),临床成功率为91%(19/21)。
  • 单纯球囊扫取清除结石占43%;需胆道镜者占43%,其中89%使用EHL。
  • ERCP后胰腺炎发生2例(10%),均为轻度。

临床怎么用

  • 对胆囊切除术后综合征患者应识别胆囊管残端结石这一胆源性病因。
  • ERCP可作为微创替代方案,对嵌顿或大结石应预先准备胆道镜及EHL。

局限性

  • 回顾性设计且样本量小(21例),结论需更大型前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Cystic duct remnant (CDR) stones are an under-recognized biliary cause of postcholecystectomy syndrome (PCS). Surgical excision has been the traditional treatment; however, ERCP may offer a less invasive alternative. METHODS: We conducted a retrospective multicenter study of patients with PCS who underwent ERCP for CDR stones. The primary outcome was technical success (complete stone clearance); secondary outcomes were clinical success and adverse events. RESULTS: Twenty-one patients were included (mean age, 50 ± 17 years). Technical and clinical success rates were 95% (20 of 21) and 91% (19 of 21), respectively. Balloon sweep alone achieved clearance in 43%; cholangioscopy was required in 43%, with electrohydraulic lithotripsy (EHL) used in 89% of those cases. Post-ERCP pancreatitis occurred in 2 patients (10%), both mild. CONCLUSIONS: ERCP is highly effective and safe for symptomatic CDR stones. Cholangioscopy with EHL is frequently necessary and should be anticipated, particularly for impacted or large stones.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Arif Y, Tielleman T, Alchirazi K, et al. Endoscopic management of cystic duct remnant stones causing postcholecystectomy syndrome: a multicenter experience. Gastrointest Endosc. 2026. PMID: 42575378. doi:10.1016/j.gie.2026.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。